Bone metabolic changes during pregnancy: A period of vulnerability to osteoporosis and fracture

European Journal of Endocrinology

Volumn 172, Issue 2, 2015, Pages R53-R65

  Sanz Salvador, Lucía ^a   García Pérez, Miguel Angel ^b   Tarín, Juan J ^b   Cano, Antonio ^c  

^a Fundació n para la Investigació n Sanitaria y Biomédica FISABIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; ESTROGEN; FIBROBLAST GROWTH FACTOR 23; GROWTH HORMONE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE[1-34]; PLACENTAL GROWTH HORMONE; PROLACTIN; SCLEROSTIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; VITAMIN D;

BONE DENSITY; BONE METABOLISM; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DUAL ENERGY X RAY ABSORPTIOMETRY; FIRST TRIMESTER PREGNANCY; FRAGILITY FRACTURE; HIP FRACTURE; HISTOLOGY; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PERCUTANEOUS VERTEBROPLASTY; PREGNANCY; RADIOGRAPHY; REVIEW; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SKELETON; SPINE FRACTURE; THIRD TRIMESTER PREGNANCY; ANIMAL; FEMALE; FRACTURES, BONE; METABOLISM; OSTEOLYSIS; PHYSIOLOGY; PREGNANCY COMPLICATIONS;

ANIMALS; BONE DENSITY; BONE RESORPTION; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN D;

EID: 84920964975     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0424     Document Type: Review

References (101)

1. Khovidhunkit W & Epstein S. Osteoporosis in pregnancy. Osteoporosis International 1996 6 345-354. (doi:10.1007/BF01623007)
2. Smith R, Athanasou NA, Ostlere SJ & Vipond SE. Pregnancy-associated osteoporosis. Quarterly Journal of Medicine 1995 88 865-878.
3. Atkins D, Best D, Briss P.A., Eccles M., Falck-Ytter Y, Flottorp S, Guyatt G.H., Harbour RT, Haugh MC, Henry D et al. Grading quality of evidence and strength of recommendations. BMJ 2004 328 1490. (doi:10.1136/bmj.328.7454.1490)
4. Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Annual Review of Nutrition 2012 32 97-123. (doi:10.1146/annurev-nutr-071811-150742)
5. Cross NA, Hillman LS, Allen S.H., Krause GF & Vieira NE. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. American Journal of Clinical Nutrition 1995 61 514-523.
6. Ritchie LD, Fung EB, Halloran B.P., Turnlund JR, Van Loan MD, Cann CE & King JC. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. American Journal of Clinical Nutrition 1998 67 693-701.
7. Turner M, Barré PE, Benjamin A, Goltzman D & Gascon-Barré M. Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy? Mineral and Electrolyte Metabolism 1988 14 246-252.
8. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281. (doi:10.1056/NEJMra070553)
9. Karras SN, Anagnostis P, Annweiler C., Naughton DP, Petroczi A, Bili E, Harizopoulou V., Tarlatzis BC, Persinaki A, Papadopoulou F et al. Maternal vitamin D status during pregnancy: the Mediterranean reality. European Journal of Clinical Nutrition 2014 68 864-869. (doi:10.1038/ejcn.2014.80)
10. Leyssens C, Verlinden L & Verstuyf A. The future of vitamin D analogs. Frontiers in Physiology 2014 5 122. (doi:10.3389/fphys.2014.00122)
11. Bikle DD, Gee E, Halloran B & Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. Journal of Clinical Investigation 1984 74 1966-1971. (doi:10.1172/JCI111617)
12. Gomme PT & Bertolini J. Therapeutic potential of vitamin D-binding protein. Trends in Biotechnology 2004 22 340-345. (doi:10.1016/ j.tibtech.2004.05.001)
13. Dasari S, Pereira L, Reddy A.P., Michaels JE, Lu X, Jacob T, Thomas A., Rodland M, Roberts CT Jr, Gravett MG et al. Comprehensive proteomic analysis of human cervical-vaginal fluid. Journal of Proteome Research 2007 6 1258-1268. (doi:10.1021/pr0605419)
14. Liong S, Di Quinzio MK, Fleming G, Permezel M & Georgiou HM. Is vitamin D binding protein a novel predictor of labour? PLoS ONE 2013 8 e76490. (doi:10.1371/journal.pone.0076490)
15. Fudge NJ, Woodrow JP & Kovacs CS. Pregnancy rescues low bone mass and normalizes intestinal calcium absorption in Vdr null mice. Journal of Bone and Mineral Research 2006 21 (Suppl) S52.
16. Lieben L, Stockmans I, Moermans K & Carmeliet G. Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality. Bone 2013 57 123-131. (doi:10.1016/j.bone.2013.07.029)
17. Kovacs CS. Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinology and Metabolism Clinics of North America 2011 40 795-826. (doi:10.1016/j.ecl.2011.08.002)
18. Møller UK, Streym S, Mosekilde L, Heickendorff L, Flyvbjerg A, Frystyk J, Jensen LT & Rejnmark L. Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study. Osteoporosis International 2013 24 1307-1320. (doi:10.1007/s00198-012-2062-2)
19. Kirby BJ, Ma Y, Martin H.M., Favaro KL, Karaplis AC & Kovacs CS. Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. Journal of Bone and Mineral Research 2013 28 1987-2000. (doi:10.1002/jbmr.1925)
20. Ardawi MS, Nasrat HA & BA'Aqueel HS. Calcium regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. European Journal of Endocrinology 1997 137 402-409. (doi:10.1530/eje.0.1370402)
21. Hirota Y, Anai T & Miyakawa I. Parathyroid hormone-related protein levels in maternal and cord blood. American Journal of Obstetrics and Gynecology 1997 177 702-706. (doi:10.1016/S0002-9378(97)70167-4)
22. Black AJ, Topping J, Durham B., Farquharson RG & Fraser WD. A detailed assessment of alterations in bone turnover, calcium homeo-stasis, and bone density in normal pregnancy. Journal of Bone and Mineral Research 2000 15 557-563. (doi:10.1359/jbmr.2000.15.3.557)
23. Wysolmerski JJ. Parathyroid hormone-related protein: an update. Journal of Clinical Endocrinology and Metabolism 2012 97 2947-2956. (doi:10.1210/jc.2012-2142)
24. Care AD, Abbas SK, Pickard D.W., Barri M., Drinkhill M, Findlay JB, White IR & Caple IW. Stimulation of ovine placental transport of calcium and magnesium by mid-molecule fragments of human parathyroid hormone-related protein. Experimental Physiology 1990 75 605-608.
25. Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocrine Journal 2008 55 959-966. (doi:10.1507/endocrj.K08E-092)
26. Riccardi D, Brennan SC & Chang W. The extracellular calcium-sensing receptor, CaSR, in fetal development. Best Practice & Research. Clinical Endocrinology & Metabolism 2013 27 443-453. (doi:10.1016/j.beem.2013.02.010)
27. Kovacs CS, Lanske B, Hunzelman J.L., Guo J., Karaplis AC & Kronenberg HM. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. PNAS 1996 93 15233-15238. (doi:10.1073/pnas.93.26.15233)
28. Simmonds CS, Karsenty G, Karaplis AC & Kovacs CS. Parathyroid hormone regulates fetal-placental mineral homeostasis. Journal of Bone and Mineral Research 2010 25 594-605. (doi:10.1359/jbmr.090825)
29. Chellakooty M, Vangsgaard K, Larsen T., Scheike T, Falck-Larsen J, Legarth J, Andersson A.M., Main KM, Skakkebaek NE & Juul A. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. Journal of Clinical Endocrinology and Metabolism 2004 89 384-391. (doi:10.1210/jc.2003-030282)
30. Lacroix MC, Guibourdenche J, Frendo J.L., Muller F & Evain-Brion D. Human placental growth hormone - a review. Placenta 2002 23 (Suppl A) S87-S94. (doi:10.1053/plac.2002.0811)
31. Baumann GP. Growth hormone isoforms. Growth Hormone & IGF Research 2009 19 333-340. (doi:10.1016/j.ghir.2009.04.011)
32. Mirlesse V, Frankenne F, Alsat E., Poncelet M, Hennen G & Evain-Brion D. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatric Research 1993 34 439-442. (doi:10.1203/00006450-199310000-00011)
33. Caufriez A, Frankenne F, Hennen G & Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. American Journal of Physiology 1993 265 E572-E577.
34. Boyce BF & Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Archives of Biochemistry and Biophysics 2008 473 139-146. (doi:10.1016/j.abb.2008.03.018)
35. Sigl V & Penninger JM. RANKL/RANK - from bone physiology to breast cancer. Cytokine & Growth Factor Reviews 2014 25 205-214. (doi:10.1016/j.cytogfr.2014.01.002)
36. Rachner TD, Khosla S & Hofbauer LC. Osteoporosis: now and the future. Lancet 2011 377 1276-1287. (doi:10.1016/S0140-6736(10)62349-5)
37. Boyle WJ, Simonet WS & Lacey DL. Osteoclast differentiation and activation. Nature 2003 423 337-342. (doi:10.1038/nature01658)
38. Naylor KE, Rogers A, Fraser R.B., Hall V., Eastell R & Blumsohn A. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. Journal of Clinical Endocrinology and Metabolism 2003 88 5361-5365. (doi:10.1210/jc.2003-030486)
39. Hong JS, Santolaya-Forgas J, Romero R., Espinoza J, Gonçalves LF, Kim Y.M., Edwin S., Yoon BH, Nien JK, Hassan S et al. Maternal plasma osteoprotegerin concentration in normal pregnancy. American Journal of Obstetrics and Gynecology 2005 193 1011-1015. (doi:10.1016/j.ajog.2005.06.051)
40. Lonergan M, Aponso D, Marvin K.W., Helliwell RJ, Sato TA, Mitchell MD, Chaiwaropongsa T, Romero R & Keelan JA. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. Journal of Clinical Endocrinology and Metabolism 2003 88 3835-3844. (doi:10.1210/jc.2002-021905)
41. Briana DD, Boutsikou M, Baka S., Hassiakos D, Gourgiotis D & Malamitsi-Puchner A. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. Neonatology 2009 96 132-136. (doi:10.1159/000211666)
42. Dorota DK, Bogdan KG, Mieczyslaw G, Bozena LG & Jan O. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertension in Pregnancy 2012 31 166-176. (doi:10.3109/10641955.2010.484084)
43. Findlay DM & Atkins GJ. Relationship between serum RANKL and RANKL in bone. Osteoporosis International 2011 22 2597-2602. (doi:10.1007/s00198-011-1740-9)
44. Schramek D, Sigl V & Penninger JM. RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. Trends in Endocrinology and Metabolism 2011 22 188-194. (doi:10.1016/j.tem.2011.02.007)
45. Dallas SL, Prideaux M & Bonewald LF. The osteocyte: an endocrine cell. and more. Endocrine Reviews 2013 34 658-690. (doi:10.1210/er.2012-1026)
46. Qing H, Ardeshirpour L, Pajevic P.D., Dusevich V., Jähn K, Kato S., Wysolmerski J & Bonewald LF. Demonstration of osteocytic perila-cunar/canalicular remodeling in mice during lactation. Journal of Bone and Mineral Research 2012 27 1018-1029. (doi:10.1002/jbmr.1567)
47. McClung MR, Grauer A, Boonen S., Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster J.Y., Zanchetta JR, Wasserman SM et al. Romosozumab in postmenopausal women with low bone mineral density. New England Journal of Medicine 2014 370 412-420. (doi:10.1056/NEJMoa1305224)
48. Berndt T & Kumar R. Phosphatonins and the regulation of phosphate homeostasis. Annual Review of Physiology 2007 69 341-359. (doi:10.1146/annurev.physiol.69.040705.141729)
49. Godang K, Frøslie KF, Henriksen T., Isaksen GA, Voldner N, Lekva T, Ueland T & Bollerslev J. Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates. European Journal of Endocrinology 2013 168 371-378. (doi:10.1530/EJE-12-0531)
50. Frost M, Andersen T, Gossiel F., Hansen S, Bollerslev J, van Hul W, Eastell R, Kassem M & Brixen K. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. Journal of Bone and Mineral Research 2011 26 1721-1728. (doi:10.1002/jbmr.376)
51. Khosla S, Oursler MJ & Monroe DG. Estrogen and the skeleton. Trends in Endocrinology and Metabolism 2012 23 576-581. (doi:10.1016/j.tem.2012.03.008)
52. Seriwatanachai D, Krishnamra N & van Leeuwen JP. Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. Journal of Cellular Biochemistry 2009 107 677-685. (doi:10.1002/jcb.22161)
53. Seriwatanachai D, Thongchote K, Charoenphandhu N., Pandaranandaka J, Tudpor K, Teerapornpuntakit J., Suthiphongchai T & Krishnamra N. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio. Bone 2008 42 535-546. (doi:10.1016/j.bone.2007.11.008)
54. Polatti F, Capuzzo E, Viazzo F., Colleoni R & Klersy C. Bone mineral changes during and after lactation. Obstetrics and Gynecology 1999 94 52-56. (doi:10.1016/S0029-7844(99)00236-7)
55. Tuppurainen M, Kröger H, Saarikoski S., Honkanen R & Alhava E. The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri-and postmenopausal women. Maturitas 1995 21 137-145. (doi:10.1016/0378-5122(94)00878-B)
56. Ip S, Chung M, Raman G., Chew P, Magula N, DeVine D., Trikalinos T & Lau J. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report/Technology Assessment 2007 153 1-186.
57. Kauppi M, Heliövaara M, Impivaara O., Knekt P & Jula A. Parity and risk of hip fracture in postmenopausal women. Osteoporosis International 2011 22 1765-1771. (doi:10.1007/s00198-010-1392-1)
58. Purdie DW, Aaron JE & Selby PL. Bone histology and mineral homeo-stasis in human pregnancy. British Journal of Obstetrics and Gynaecology 1988 95 849-854. (doi:10.1111/j.1471-0528.1988.tb06568.x)
59. Tojo Y, Kurabayashi T, Honda A., Yamamoto Y, Yahata T, Takakuwa K & Tanaka K. Bone structural and metabolic changes at the end of pregnancy and lactation in rats. American Journal of Obstetrics and Gynecology 1998 178 180-185. (doi:10.1016/S0002-9378(98)70649-0)
60. Lees CJ & Jerome CP. Effects of pregnancy and lactation on bone in cynomolgus macaques: histomorphometric analysis of iliac biopsies. Bone 1998 22 545-549. (doi:10.1016/S8756-3282(98)00032-5)
61. Holmberg-Marttila D., Sievänen H & Tuimala R. Changes in bone mineral density during pregnancy and postpartum: prospective data on five women. Osteoporosis International 1999 10 41-46. (doi:10.1007/ s001980050192)
62. More C, Bettembuk P, Bhattoa HP & Balogh A. The effects of pregnancy and lactation on bone mineral density. Osteoporosis International 2001 12 732-737. (doi:10.1007/s001980170048)
63. Ulrich U, Miller PB, Eyre D.R., Chesnut CH III, Schlebusch H & Soules MR. Bone remodeling and bone mineral density during pregnancy. Archives of Gynecology and Obstetrics 2003 268 309-316. (doi:10.1007/s00404-002-0410-8)
64. Drinkwater BL & Chesnut CH III. Bone density changes during pregnancy and lactation in active women: a longitudinal study. Bone and Mineral 1991 14 153-160. (doi:10.1016/0169-6009(91)90092-E)
65. Pearson D, Kaur M, San P., Lawson N, Baker P & Hosking D. Recovery of pregnancy mediated bone loss during lactation. Bone 2004 34 570-578. (doi:10.1016/j.bone.2003.11.005)
66. Naylor KE, Iqbal P, Fledelius C., Fraser RB & Eastell R. The effect of pregnancy on bone density and bone turnover. Journal of Bone and Mineral Research 2000 15 129-137. (doi:10.1359/jbmr.2000.15.1.129)
67. Sowers M, Crutchfield M, Jannausch M., Updike S & Corton G. A prospective evaluation of bone mineral change in pregnancy. Obstetrics and Gynecology 1991 77 841-845.
68. Olausson H, Laskey MA, Goldberg GR & Prentice A. Changes in bone mineral status and bone size during pregnancy and the influences of body weight and calcium intake. American Journal of Clinical Nutrition 2008 88 1032-1039.
69. Møller UK, Streym S, Mosekilde L & Rejnmark L. Changesinbonemineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporosis International 2012 23 1213-1223. (doi:10.1007/s00198-011-1654-6)
70. Sowers MF, Scholl T, Harris L & Jannausch M. Bone loss in adolescent and adult pregnant women. Obstetrics and Gynecology 2000 96 189-193. (doi:10.1016/S0029-7844(00)00903-0)
71. Kraemer B, Schneider S, Rothmund R., Fehm T, Wallwiener D & Solomayer EF. Influence of pregnancy on bone density: a risk factor for osteoporosis? Measurements of the calcaneus by ultrasonometry. Archives of Gynecology and Obstetrics 2012 285 907-912. (doi:10.1007/s00404-011-2076-6)
72. Gambacciani M, Spinetti A, Gallo R., Cappagli B, Teti GC & Facchini V. Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation. American Journal of Obstetrics and Gynecology 1995 173 890-893. (doi:10.1016/0002-9378(95)90361-5)
73. Yamaga A, Taga M, Minaguchi H & Sato K. Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. Journal of Clinical Endocrinology and Metabolism 1996 81 752-756.
74. Paoletti AM, Orrù M, Floris L, Guerriero S, Ajossa S, Romagnino S & Melis GB. Pattern of bone markers during pregnancy and their changes after delivery. Hormone Research 2003 59 21-29. (doi:10.1159/000067935)
75. More C, Bhattoa HP, Bettembuk P & Balogh A. The effects of pregnancy and lactation on hormonal status and biochemical markers of bone turnover. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003 106 209-213. (doi:10.1016/S0301-2115(02)00237-3)
76. Maliha G, Morgan J & Vrahas M. Transient osteoporosis of pregnancy. Injury 2012 43 1237-1241. (doi:10.1016/j.injury.2012.03.009)
77. Steib-Furno S., Luc M, Pham T., Armingeat T, Porcu G, Gamerre M., Chagnaud C & Lafforgue P. Pregnancy-related hip diseases: incidence and diagnoses. Joint, Bone, Spine 2007 74 373-378. (doi:10.1016/j.jbspin.2006.12.001)
78. Phillips AJ, Ostlere SJ & Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporosis International 2000 11 449-454. (doi:10.1007/s001980070113)
79. Dunne F, Walters B, Marshall T & Heath DA. Pregnancy associated osteoporosis. Clinical Endocrinology 1993 39 487-490. (doi:10.1111/j.1365-2265.1993.tb02398.x)
80. Smith R, Stevenson JC, Winearls C.G., Woods CG & Wordsworth BP. Osteoporosis of pregnancy. Lancet 1985 1 1178-1180. (doi:10.1016/S0140-6736(85)92861-2)
81. Kanis JA, Oden A, Johansson H., Borgström F, Ström O & McCloskey E. FRAX and its applications to clinical practice. Bone 2009 44 734-743. (doi:10.1016/j.bone.2009.01.373)
82. Carbone LD, Palmieri GM, Graves SC & Smull K. Osteoporosis of pregnancy: long-term follow-up of patients and their offspring. Obstetrics and Gynecology 1995 86 664-666. (doi:10.1016/0029-7844(95)00226-H)
83. Campos-Obando N., Oei L, Hoefsloot L.H., Kiewiet RM, Klaver CC, Simon ME & Zillikens MC. Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. Journal of Clinical Endocrinology and Metabolism 2014 99 1107-1111. (doi:10.1210/jc.2013-3238)
84. Cano-Marquina A., Garćia-Pérez MA, Tarín JJ & Cano A. Transient regional osteoporosis. Maturitas 2014 77 324-329. (doi:10.1016/j.maturitas.2014.01.012)
85. Stumpf UC, Kurth AA, Windolf J & Fassbender WJ. Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease, A review of two cases in short- and long-term follow-up. Advances in Medical Sciences 2007 52 94-97.
86. Ofluoglu O & Ofluoglu D. A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures. Rheumatology International 2008 29 197-201. (doi:10.1007/s00296-008-0641-5)
87. Groen RS, Bae JY & Lim KJ. Fear of the unknown: ionizing radiation exposure during pregnancy. American Journal of Obstetrics and Gynecology 2012 206 456-462. (doi:10.1016/j.ajog.2011.12.001)
88. Bazzocchi A, Garzillo G, Fuzzi F., Diano D, Albisinni U, Salizzoni E., Battista G & Guglielmi G. Localizer sequences of magnetic resonance imaging accurately identify osteoporotic vertebral fractures. Bone 2014 61 158-163. (doi:10.1016/j.bone.2014.01.013)
89. Vande Berg B.C., Malghem JJ, Lecouvet F.E., Jamart J & Maldague BE. Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings. Radiology 1999 212 527-535. (doi:10.1148/radiology.212.2.r99au03527)
90. Patlas N, Golomb G, Yaffe P., Pinto T, Breuer E & Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999 60 68-73. (doi:10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H)
91. Ornoy A, Wajnberg R & Diav-Citrin O. The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. Reproductive Toxicology 2006 22 578-579. (doi:10.1016/j.reprotox.2006.05.009)
92. Levy S, Fayez I, Taguchi N., Han JY, Aiello J, Matsui D, Moretti M., Koren G & Ito S. Pregnancy outcome following in utero exposure to bisphosphonates. Bone 2009 44 428-430. (doi:10.1016/j.bone.2008.11.001)
93. Djokanovic N, Klieger-Grossmann C & Koren G. Does treatment with bisphosphonates endanger the human pregnancy? Journal of Obstetrics and Gynaecology Canada 2008 30 1146-1148.
94. Rutgers-Verhage A.R., de Vries TW & Torringa MJ. No effects of bispho-sphonates on the human fetus. Birth Defects Research. Part A, Clinical and Molecular Teratology 2003 67 203-204. (doi:10.1002/bdra.10016)
95. Osullivan SM, Grey AB, Singh R & Reid IR. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporosis International 2006 17 1008-1012. (doi:10.1007/s00198-006-0112-3)
96. Ozturk C, Atamaz FC, Akkurt H & Akkoc Y. Pregnancy-associated osteoporosis presenting severe vertebral fractures. Journal of Obstetrics and Gynaecology Research 2014 40 288-292. (doi:10.1111/jog.12157)
97. Hellmeyer L, Boekhoff J & Hadji P. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecological Endocrinology 2010 26 725-728. (doi:10.3109/09513591003649831)
98. Lampropoulou-Adamidou K., Trovas G, Stathopoulos IP & Papaioannou NA. Case report: Teriparatide treatment in a case of severe pregnancy- and lactation-associated osteoporosis. Hormones 2012 11 495-500. (doi:10.14310/horm.2002.1383)
99. Choe EY, Song JE, Park K.H., Seok H., Lee EJ, Lim SK & Rhee Y. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. Journal of Bone and Mineral Metabolism 2012 30 596-601. (doi:10.1007/s00774-011-0334-0)
100. Kim HW, Song JW, Kwon A & Kim IH. Percutaneous vertebroplasty for pregnancy-associated osteoporotic vertebral compression fractures. Journal of Korean Neurosurgical Society 2010 47 399-402. (doi:10.3340/jkns.2010.47.5.399)
101. Bonacker J, Janousek M & Kröber M. Pregnancy-associated osteoporosis with eight fractures in the vertebral column treated with kyphoplasty and bracing: a case report. Archives of Orthopaedic and Trauma Surgery 2014 134 173-179. (doi:10.1007/s00402-013-1912-5)